The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects

Seandel, M., Shia, J., Linkov, I., Maki, R. G., Antonescu, C. R., Dupont, J. (October 2006) The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects. Clin Cancer Res, 12 (20 Pt ). pp. 6203-4. ISSN 1078-0432 (Print)1078-0432 (Linking)

URL: https://www.ncbi.nlm.nih.gov/pubmed/17062698
DOI: 10.1158/1078-0432.CCR-06-1292
Item Type: Paper
Uncontrolled Keywords: Angiogenesis Inhibitors/*therapeutic use Antineoplastic Agents/*therapeutic use Cell Division/drug effects Enzyme Inhibitors/*therapeutic use Female Gastrointestinal Stromal Tumors/drug therapy/*pathology/*surgery Humans Indoles/*therapeutic use Middle Aged Neoplasm, Residual/surgery Phosphotransferases/antagonists & inhibitors Pyrroles/*therapeutic use Treatment Outcome
Subjects: diseases & disorders > cancer > drugs and therapies
diseases & disorders > cancer > cancer types > gastrointestinal stromal tumors
CSHL Authors:
Communities: CSHL labs > Maki lab
Depositing User: Matt Covey
Date: 15 October 2006
Date Deposited: 26 Oct 2016 19:53
Last Modified: 26 Oct 2016 19:53
Related URLs:
URI: http://repository.cshl.edu/id/eprint/33666

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving